Diagnostic usefulness and prognostic impact of CD200 expression in lymphoid malignancies and plasma cell myeloma
about
CD200/BTLA deletions in pediatric precursor B-cell acute lymphoblastic leukemia treated according to the EORTC-CLG 58951 protocol.Clinical impact of CD200 expression in patients with acute myeloid leukemia and correlation with other molecular prognostic factors.Ibrutinib enhances chimeric antigen receptor T-cell engraftment and efficacy in leukemiaLow expression of CD200 predicts shorter time-to-treatment in chronic lymphocytic leukemiaIntragenic Variations in BTLA Gene Influence mRNA Expression of BTLA Gene in Chronic Lymphocytic Leukemia Patients and Confer Susceptibility to Chronic Lymphocytic Leukemia.Immunological dysregulation in multiple myeloma microenvironment.Immunophenotype of normal vs. myeloma plasma cells: Toward antibody panel specifications for MRD detection in multiple myeloma.Flow cytometric analysis of CD200 expression by pulmonary small cell carcinoma.Chronic lymphocytic leukemia and small lymphocytic lymphoma: two faces of the same disease.Standardisation of minimal residual disease in multiple myeloma.Upregulation of CD200 is associated with regulatory T cell expansion and disease progression in multiple myeloma.The role of tumor expression of CD200 in tumor formation, metastasis and susceptibility to T lymphocyte adoptive transfer therapy.Quantitative flow cytometric evaluation of CD200, CD123, CD43 and CD52 as a tool for the differential diagnosis of mature B-cell neoplasms.CD200 expression in plasma cells of nonmyeloma immunoproliferative disorders: clinicopathologic features and comparison with plasma cell myeloma.Quantitative assessment of informative immunophenotypic markers increases the diagnostic value of immunophenotyping in mature CD5-positive B-cell neoplasms.Multiple myeloma: New surface antigens for the characterization of plasma cells in the era of novel agents.CD200 expression in mantle cell lymphoma identifies a unique subgroup of patients with frequent IGHV mutations, absence of SOX11 expression, and an indolent clinical course.Prognostic impact of CD200 and CD56 expression in adult acute lymphoblastic leukemia patients.Prognostic impact of CD200 and CD56 expression in pediatric B-cell acute lymphoblastic leukemia patients.CD200 has an important role in the differential diagnosis of mature B-cell neoplasms by multiparameter flow cytometry.CD200 Expression in Neuroendocrine Neoplasms.Flow Cytometric Patterns of CD200 and CD1d Expression Distinguish CD10-Negative, CD5-Negative Mature B-Cell Lymphoproliferative Disorders.Chronic lymphocytic leukaemia
P2860
Q36115668-AA65D23F-1201-4A05-8304-9BE827F382E9Q36557537-8234A511-A25B-4FE6-A8D8-6155D562A6E7Q36651344-08F06BDB-94DB-4595-9EB7-A01934C0D8A7Q37046389-8CACFB45-C6F2-4002-B3EA-D594069A16A7Q37678076-011856BF-0F3B-4733-B6F1-242598314879Q38228353-007DED1E-2734-45AE-BC81-3D2117BE245DQ38534837-23D314D0-C4DA-4AF4-813F-F008BC13A96BQ38941113-ABC5DF5A-72BC-4FFD-AA1A-B0F8195C17DBQ39034465-91B2C143-8CFC-4D3B-B681-31D9E7B0FA27Q39410899-39FE8FB3-7029-4ADD-8386-53E0F28EEA82Q41191111-B93AF382-DE6C-49B0-AE9F-4ABDD68BB14CQ41474685-AB9B85DF-5D56-4FCD-9811-96F09C38D8F3Q41491139-5AF0DCCE-2979-4EDB-93EC-91D4AC64FA01Q46826314-C65BCC5A-1283-4FEE-885B-62A6A1591E1FQ47268166-A81AA321-BC87-45E3-BC25-4BE55673FD00Q48958626-C2D0A486-B0E1-4025-AB6F-4E1857C22BF5Q49564224-C1CA52E2-4A43-4E72-82BE-8428A21E739AQ49838769-A7B50FEB-D277-41C8-80CB-0644B2A8616EQ49964009-7B1BBAA6-2BB9-479C-AC13-340701A0553EQ51140746-51C1BEB2-1062-4E33-9944-8DCBB717E18CQ51805000-0A603B44-E768-43F6-AB69-EC187F1B9877Q52863070-CB1E4E05-1A99-4C2B-83D6-12EDED4AC1C2Q56270980-D82379AD-8A28-43C2-AFC9-6F149FF31D55
P2860
Diagnostic usefulness and prognostic impact of CD200 expression in lymphoid malignancies and plasma cell myeloma
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Diagnostic usefulness and prog ...... ancies and plasma cell myeloma
@en
Diagnostic usefulness and prog ...... ncies and plasma cell myeloma.
@nl
type
label
Diagnostic usefulness and prog ...... ancies and plasma cell myeloma
@en
Diagnostic usefulness and prog ...... ncies and plasma cell myeloma.
@nl
prefLabel
Diagnostic usefulness and prog ...... ancies and plasma cell myeloma
@en
Diagnostic usefulness and prog ...... ncies and plasma cell myeloma.
@nl
P2093
P2860
P356
P1476
Diagnostic usefulness and prog ...... ancies and plasma cell myeloma
@en
P2093
Daisy Alapat
Jean Coviello-Malle
John D Shaughnessy
Pingping Qu
Rebecca Owens
Robert B Lorsbach
P2860
P304
P356
10.1309/AJCP59UORCYZEVQO
P407
P577
2012-01-01T00:00:00Z